Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell...

Area of Science:

• Oncology
• Molecular Biology
• Gastroenterology

Background:

• Programmed cell death 4 (PDCD4) is a tumor suppressor frequently downregulated in cancers.
• PDCD4 expression is regulated by miR-21 and activated protein kinase B (Akt).
• Esophageal squamous cell neoplasia progression involves molecular alterations affecting key regulatory proteins.

Purpose of the Study:

• To investigate the expression patterns of PDCD4, phosphorylated Akt (pAkt), and miR-21 in esophageal squamous intraepithelial neoplasia (IEN) and intramucosal carcinoma (IM-SSC).
• To evaluate the potential of PDCD4 down-regulation as an early diagnostic biomarker for esophageal squamous cell neoplasia.

Main Methods:

• Immunohistochemistry was used to assess PDCD4 and pAkt expression in 53 esophageal tissue samples (33 IEN, 20 IM-SSC) and 50 normal controls.
• Quantitative real-time polymerase chain reaction and in situ hybridization were employed to measure miR-21 expression in a subset of samples.
• Statistical analysis (P < 0.001) was performed to determine the significance of expression changes.

Main Results:

• Normal esophageal squamous epithelium showed strong nuclear PDCD4 immunostaining.
• PDCD4 expression was significantly lower in both low-grade and high-grade IEN and IM-SSC compared to normal controls (P < 0.001).
• pAkt and miR-21 expression levels were significantly elevated across the spectrum of preneoplastic and neoplastic esophageal lesions.

Conclusions:

• Down-regulation of PDCD4, assessed via immunohistochemistry, is a significant indicator of early-stage esophageal squamous cell neoplasia.
• The combined assessment of PDCD4, pAkt, and miR-21 provides valuable information for the histological evaluation of esophageal lesions.
• PDCD4 serves as a reliable biomarker for the early detection of esophageal squamous cell neoplasia.